Sotac Pharmaceuticals (NSE:SOTAC) Long-Term Debt : ₹114 Mil (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sotac Pharmaceuticals Long-Term Debt?

Sotac Pharmaceuticals's Long-Term Debt for the quarter that ended in Sep. 2024 was ₹114 Mil.

Sotac Pharmaceuticals's quarterly Long-Term Debt declined from Mar. 2024 (₹121 Mil) to Jun. 2024 (₹0 Mil) but then increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹114 Mil).

Sotac Pharmaceuticals's annual Long-Term Debt increased from Mar. 2022 (₹10 Mil) to Mar. 2023 (₹78 Mil) and increased from Mar. 2023 (₹78 Mil) to Mar. 2024 (₹121 Mil).

Sotac Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for Sotac Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sotac Pharmaceuticals Long-Term Debt Chart

Sotac Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

61.48

92.79

9.70

77.69

121.31

Sotac Pharmaceuticals Quarterly Data
	Mar20	Mar21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial								80.18	-	121.31	-	114.05

Sotac Pharmaceuticals (NSE:SOTAC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Sotac Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Sotac Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sotac Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sotac Pharmaceuticals Ltd (NSE:SOTAC) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

Plot No. PF-21, Near ACME Pharma, Opposite Teva Pharma Sanand GIDC-II, Sanand, Ahmedabad, GJ, IND, 382110

Website

https://www.sotacpharma.com

Sotac Pharmaceuticals Ltd is a pharma manufacturer, specializing in the manufacturing of a wide range of pharmaceutical products such as Non-Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non-Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray, and cream.

Sotac Pharmaceuticals Headlines

No Headlines